{"id":1288,"date":"2018-10-29T14:08:07","date_gmt":"2018-10-29T14:08:07","guid":{"rendered":"http:\/\/www.iuibs.ulpgc.es\/?p=1288"},"modified":"2018-10-29T14:14:20","modified_gmt":"2018-10-29T14:14:20","slug":"cancer-mama","status":"publish","type":"post","link":"https:\/\/www.iuibs.ulpgc.es\/web-grupos\/blog\/2018\/10\/29\/cancer-mama\/","title":{"rendered":"El iUIBS avanza en investigaciones para tratar el c\u00e1ncer de mama"},"content":{"rendered":"<p>De la mano del grupo de investigaci\u00f3n,\u00a0<a href=\"http:\/\/www.iuibs.ulpgc.es\/biopharm\/\" target=\"_blank\" rel=\"noopener\">Farmacolog\u00eda Molecular y Traslacional &#8211; Biopharm<\/a>, el\u00a0<a href=\"http:\/\/www.iuibs.ulpgc.es\/grupos\/#SID76_5_tgl\" target=\"_blank\" rel=\"noopener\">iUIBS<\/a>\u00a0 ha desarrollado un f\u00e1rmaco capaz de tratar el c\u00e1ncer de mama m\u00e1s agresivo.<\/p>\n<p>De esta manera, se avanza en la lucha de esta enfermedad que afecta a un gran n\u00famero de mujeres ya que el f\u00e1rmaco tambi\u00e9n beneficiar\u00e1 a pacientes que no responden al tratamiento m\u00e1s convencional.<\/p>\n<p><a href=\"http:\/\/www.iuibs.ulpgc.es\/wp-content\/uploads\/2018\/10\/db2cfee3-601b-4c67-a93f-d10e2cf5d08f.jpg\" target=\"_blank\" rel=\"noopener\">Ver art\u00edculo de prensa<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>De la mano del grupo de investigaci\u00f3n,\u00a0Farmacolog\u00eda Molecular y Traslacional &#8211; Biopharm, el\u00a0iUIBS\u00a0 ha desarrollado un f\u00e1rmaco capaz de tratar el c\u00e1ncer de mama m\u00e1s agresivo. De esta manera, se avanza en la lucha de esta enfermedad que afecta a un gran n\u00famero de mujeres ya que el f\u00e1rmaco tambi\u00e9n beneficiar\u00e1 a pacientes que no [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1293,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27],"tags":[],"class_list":["post-1288","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/www.iuibs.ulpgc.es\/web-grupos\/wp-json\/wp\/v2\/posts\/1288","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.iuibs.ulpgc.es\/web-grupos\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.iuibs.ulpgc.es\/web-grupos\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.iuibs.ulpgc.es\/web-grupos\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.iuibs.ulpgc.es\/web-grupos\/wp-json\/wp\/v2\/comments?post=1288"}],"version-history":[{"count":2,"href":"https:\/\/www.iuibs.ulpgc.es\/web-grupos\/wp-json\/wp\/v2\/posts\/1288\/revisions"}],"predecessor-version":[{"id":1292,"href":"https:\/\/www.iuibs.ulpgc.es\/web-grupos\/wp-json\/wp\/v2\/posts\/1288\/revisions\/1292"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.iuibs.ulpgc.es\/web-grupos\/wp-json\/wp\/v2\/media\/1293"}],"wp:attachment":[{"href":"https:\/\/www.iuibs.ulpgc.es\/web-grupos\/wp-json\/wp\/v2\/media?parent=1288"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.iuibs.ulpgc.es\/web-grupos\/wp-json\/wp\/v2\/categories?post=1288"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.iuibs.ulpgc.es\/web-grupos\/wp-json\/wp\/v2\/tags?post=1288"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}